Diabetes Health Enhancement Program to Improve Health of People With Diabetes

Robert Wood Johnson Foundation

Status and phase

Completed

Phase 3

Conditions

Diabetes

Treatments

Behavioral: DHEP

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT00291590

DHEP001

Details and patient eligibility

About

Management of chronic diseases, such as diabetes, relies upon the health care providers and the patients self-care. Self management programs for diabetes that target self-empowerment tools have been found to be effective in some studies, but have not typically included individuals on Medicaid.

Our goal for this trial was to observe if patients participating in such a program could decrease glycated hemoglobin levels, improve health status and improve self-care practices.

Full description

Design, Setting and Population: A Phase 3, one year prospective trial, randomized to intervention or control (usual care) with Medicaid or dual-Medicare beneficiaries, with diabetes, aged 40-85 years old residing in South King County, Washington.

Intervention: A targeted, multi-component, self-management program incorporating a stage-of-change approach to overcome barriers and facilitate life-style behavior changes to achieve patient-driven health action plans for nutrition or exercise goals.

Main Outcome Measures: Glycemic control (HbA1c), physical and mental health, self-care practices.

Recruitment Status: Completed: participants are no longer being recruited; data analysis is complete.

Sex

All

Ages

40 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Insured under Medicaid (SSI) or dual enrolled under Medicaid and Medicare for at least one year
Diagnosed type 1 or type 2 diabetes for at least 1 year (>1 inpatient or >2 outpatients visits with ICD-9 codes 250.00-250.9x, or prescriptions for insulin and/or oral hyperglycemic medications)
Aged 40-85 years
Geographically close to the Southeast Senior Center in South King County, Washington, and have a primary care provider (not HMO).

Exclusion criteria

Serious kidney disease (serum creatinine >2.5 or end-stage renal disease)
Other serious illness that would preclude one-year study participation (dementia, terminal illness, organ transplantation)
Pregnancy
Inability to given informed consent.